AlphaCrest Capital Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-75,280
Closed -$2.75M 653
2022
Q3
$2.75M Buy
75,280
+34,830
+86% +$1.55M 0.17% 120
2022
Q2
$1.72M Buy
40,450
+7,730
+24% +$368K 0.08% 398
2022
Q1
$1.76M Buy
32,720
+10,510
+47% +$612K 0.1% 289
2021
Q4
$1.6M Sell
22,210
-64,630
-74% -$4.05M 0.06% 561
2021
Q3
$4.94M Sell
86,840
-9,490
-10% -$577K 0.26% 62
2021
Q2
$6.27M Buy
96,330
+3,350
+4% +$211K 0.27% 67
2021
Q1
$5.54M Buy
92,980
+54,230
+140% +$2.95M 0.31% 55
2020
Q4
$1.83M Sell
38,750
-30,610
-44% -$1.29M 0.15% 159
2020
Q3
$2.3M Buy
69,360
+51,020
+278% +$1.76M 0.25% 70
2020
Q2
$593K Sell
18,340
-20,240
-52% -$552K 0.1% 317
2020
Q1
$926K Buy
38,580
+6,400
+20% +$184K 0.11% 311
2019
Q4
$941K Sell
32,180
-27,850
-46% -$740K 0.08% 378
2019
Q3
$1.39M Sell
60,030
-55,180
-48% -$1.16M 0.08% 392
2019
Q2
$2.16M Buy
+115,210
New +$2.19M 0.19% 134
2019
Q1
Sell
-14,910
Closed -$203K 904
2018
Q4
$203K Buy
+14,910
New +$214K 0.06% 596

Other funds holding LRCX

AlphaCrest Capital Management's LRCX Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Lam Research (LRCX) in Q4 2022, closing a stake of 75,280 shares — an estimated $2.75M sold.

AlphaCrest Capital Management first reported a position in LRCX in Q4 2018 and held it in 15 quarters. The position peaked at $6.27M in Q2 2021. 1,346 funds tracked by Wall St. Rank hold LRCX as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Lam Research position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 75,280 Lam Research shares in Q4 2022, an estimated $2.75M.
  • AlphaCrest Capital Management first reported a position in Lam Research in Q4 2018 and held it in 15 quarters.
  • AlphaCrest Capital Management's Lam Research position peaked at $6.27M in Q2 2021.
  • 1,346 funds tracked by Wall St. Rank held Lam Research as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.